ICR amongst top UK universities for industry and academic partnerships and public engagement 24 Oct 2023 The ICR has ranked as one of the UK's best higher education institutions at engaging with industry, academic partners and the wider public, in the Government's latest Knowledge Exchange Framework (KEF). Find out more Show/Hide
‘Molecular glue degrader’ reaches cancer trial following ICR research programme 23 Feb 2023 The biotechnology company Monte Rosa Therapeutics – originally a spin-out from research at The Institute of Cancer Research, London – has announced that the first patient has received their ‘molecular glue degrader’ drug as part of a clinical trial in oncology. Find out more Show/Hide